- Worldwide Rank #2,512,632
- Follower/Following Ratio 11.44
- Daily New Followers 0
Mederma Twitter Stats
@Mederma - Tracking Mederma Twitter profile since May 9, 2011
The official Twitter account of Mederma® Scar and Mederma® Stretch Marks Therapy. Find us on Facebook at https://t.co/hQPwpI2Of5 or visit https://t.co/9sAjrP9d69
Mederma, also known as @Mederma has a reasonably significant presence on Twitter and is ranked by us in the 30% percentile for account strength. Active on Twitter since November 2010, Mederma made it to having a respectable 4,357 Twitter followers and to being ranked 2,512,632 for number of followers among all Twitter users.
Uh-oh... seems like someone has fallen asleep while on duty and is dropping in social relevance. The plot thickens when considering Mederma's follower-to-following ratio, which is 11.44.
@Mederma doesn't tweet all that much, with an average of 1 tweet(s) per day in the past 30 days. However this seems to be a big change from a total of 4,012 since @Mederma joined Twitter.
This account is tracked by us for quite some time now, actually since May 2011. As of January 19 2017 we track 263.746.726 Twitter accounts, so feel free to search for other accounts you're interested in and reveal their Twitter story!
@Mederma has posted 23 tweets in the last 30 days, which translates to an average of 0.8 tweets per day.
Mederma Twitter Followers
@Mederma has 4,357 followers on Twitter.
This account is #2,512,632 in the worldwide rank of the most popular Twitter users.
Mederma Following on Twitter
@Mederma is following 381 Twitter accounts.
Last month this account stopped following 1 users.
Mederma Predictions & Milestones
@Mederma will hit 4,334 followers in the next 3 months, and 4,263 in one year.
You are on Mederma's Twitter stats page
We track these Twitter stats since May 9, 2011 . You can see how many followers Mederma lost or gained and what the prediction is for tomorrow or the next 15 days, together with all kinds of other stats like rank compared to all Twitter users, tweets etc.